Risk of Myopericarditis following COVID-19 mRNA vaccination in a Large Integrated Health System: A Comparison of Completeness and Timeliness of Two Methods

Katie A Sharff, David M Dancoes, Jodi L Longueil, Eric S Johnson, Paul F Lewis
doi: https://doi.org/10.1101/2021.12.21.21268209

Article usage

Article usage: December 2021 to May 2026

AbstractFullPdf
Dec 20216230176
Jan 202243229353039766
Feb 202258054492257
Mar 202229562001767
Apr 20224085941044
May 2022172031635
Jun 2022140436503
Jul 20221063166360
Aug 202283972324
Sep 2022108946515
Oct 202295033321
Nov 2022136952318
Dec 2022124342206
Jan 202375142745
Feb 202341112587
Mar 20234029208
Apr 20233121288
May 20233256109
Jun 2023390776
Jul 20232488105
Aug 20233112090
Sep 20238011397
Oct 2023425879
Nov 20232592247
Dec 20232381256
Jan 20242151353
Feb 2024215774
Mar 2024263857
Apr 2024265980
May 20242607103
Jun 20242631358
Jul 2024238767
Aug 2024210678
Sep 2024235866
Oct 20241941455
Nov 2024139749
Dec 2024101357
Jan 2025114853
Feb 20251481162
Mar 20251431268
Apr 20251581042
May 20251411360
Jun 20251342254
Jul 20252066256
Aug 20251521977
Sep 20251623564
Oct 20252242355
Nov 20251931862
Dec 202514933109
Jan 20261343468
Feb 20261206460
Mar 20261553290
Apr 20261092559
May 20261362580
Back to top
Posted December 27, 2021.
Download PDF
Data/Code
Email
Risk of Myopericarditis following COVID-19 mRNA vaccination in a Large Integrated Health System: A Comparison of Completeness and Timeliness of Two Methods
Katie A Sharff, David M Dancoes, Jodi L Longueil, Eric S Johnson, Paul F Lewis
medRxiv 2021.12.21.21268209; doi: https://doi.org/10.1101/2021.12.21.21268209
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area